IL6 and neurodegenerative disease: IL-6 like pro-inflammatory interleukins are also elevated in some neurodegenerative diseases such as Parkinson’s disease (PD) (Kwiatek-Majkusiak et al., 2020), suggesting that patients with neurodegenerative diseases may be more susceptible to the severity of COVID-19.